News | May 10, 2023
Boehringer Ingelheim begins clinical development for fibrotic diseases
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
Subscribe To Our Newsletter & Stay Updated
